Hyperosmolar hyperglycemic state epidemiology and demographics

Hyperosmolar hyperglycemic state Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hyperosmolar hyperglycemic state from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hyperosmolar hyperglycemic state epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hyperosmolar hyperglycemic state epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hyperosmolar hyperglycemic state epidemiology and demographics
CDC on Hyperosmolar hyperglycemic state epidemiology and demographics
Hyperosmolar hyperglycemic state epidemiology and demographics in the news
Blogs on Hyperosmolar hyperglycemic state epidemiology and demographics
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Hyperosmolar hyperglycemic state epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Epidemiology and Demographics

Incidence

• The exact incidence of the hyperosmolar hyperglycemic state is not known. However, it accounts for less than 1000 hospital admissions per 100,000 diabetic admissions.

Prevalence

• The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
• In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
• The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate

• Case-fatality rate of hyperosmolar hyperglycemic state varies from a low of less than 5000 per 100,000 individuals to a high of 20,000 per 100,000 individuals.
• Case-fatality rates of hyperosmolar hyperglycemic state differ according to the level of care provided and healthcare setting.

Both the crude and age-adjusted death rates for hyperglycemic crises as underlying cause decreased from 1980 to 2009. , source: Centers for Disease Control and Prevention. Diabetes Public Health Resource: Diabetes Data & Trends. http://www.cdc.gov/diabetes/statistics/mortalitydka/fratedkadiabtotals.htm

Age

• The hyperosmolar hyperglycemic state commonly affects type 2 diabetic individuals older than 65 years years of age. It is less commonly seen in children and young adults.

Race

• The prevalence and incidence of hyperosmolar hyperglycemic state is higher in black population.

Gender

• The prevalence and incidence of hyperosmolar hyperglycemic state is higher in men as compared to women.

Region

• The majority of [disease name] cases are reported in [geographical region].

• [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].